Pseudoxanthoma elasticum: Elastic fibers alterations and characterization of seru

弹性假黄瘤:弹性纤维改变和血清特征

基本信息

  • 批准号:
    7740288
  • 负责人:
  • 金额:
    $ 18.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The specific goal of this application is to identify and characterize the molecular events leading to elastic fiber alterations and calcification in pseudoxanthoma elasticum (PXE) as a pertinent disease model to better understand the dynamics governing the super-assembly and homeostasis of elastic fibers. These are large, complex molecules that provide mechanical properties to elastic tissues and regulate cell fate in many developing tissues. These fibers are essential for the development of life but how they are assembled and maintained is not fully understood. Pseudoxanthoma elasticum (PXE) is a heritable disease characterized by elastic fiber fragmentation and calcification. PXE was long thought to be a prototypic connective tissue disease but the PXE phenotype was unexpectedly linked to a gene (ABCC6) apparently unrelated to elastic fibers. We have obtained preliminary results showing that circulating factors from PXE patient sera altered elastic fibers formation in vitro. This data suggested that PXE is a metabolic disorder with secondary extracellular matrix remodeling and that circulating factors might either participate in or exacerbate the development of the disease phenotype. Hence, we hypothesize that abnormal circulating factor(s) arise in the blood as a secondary consequence of ABCC6 failure to export its substrate(s); these PXE factor(s) then percolate from the circulation into the connective tissue and either preclude the initial deposition of elastic fibers or promote structural alterations that ultimately result in their calcification. To test this hypothesis, we propose to undertake two specific aims corresponding to (i) the molecular characterization of elastic fiber defects induced by the presence of serum from PXE patients in culture of dermal fibroblasts (ii) the identification of the serum factor(s) responsible for the these defects. We expect that our proposed experiments will lead to the identification of factor(s) interfering with elastic fiber and the possible development of therapeutic measures alleviating the symptoms of PXE. We also anticipate from our studies a new level of understanding of elastic fiber formation and aging in vascular tissues. PUBLIC HEALTH RELEVANCE: Elastic fibers are large, complex molecules that are important for life by providing specific mechanical properties to elastic tissues. To understand how elastic fibers are maintained over time, we are exploring the pathologic mechanism underlying pseudoxanthoma elasticum, a heritable disease, characterized by progressive elastic fiber fragmentation and calcification.
描述(由申请人提供):本申请的具体目标是鉴定和表征导致弹性假黄瘤(PXE)中弹性纤维改变和钙化的分子事件,作为相关疾病模型,以更好地理解控制弹性纤维超组装和稳态的动力学。这些是大的复杂分子,为弹性组织提供机械特性,并调节许多发育组织中的细胞命运。这些纤维对生命的发展至关重要,但它们是如何组装和维持的还不完全清楚。弹性纤维性假黄瘤是一种以弹性纤维断裂和钙化为特征的遗传性疾病。PXE长期以来被认为是一种典型的结缔组织疾病,但PXE表型出乎意料地与一个明显与弹性纤维无关的基因(ABCC 6)有关。我们已经获得的初步结果表明,从PXE患者血清循环因子改变弹性纤维的形成在体外。这些数据表明,PXE是一种代谢紊乱与继发性细胞外基质重塑和循环因子可能参与或加剧疾病表型的发展。因此,我们假设血液中出现的异常循环因子是ABCC 6未能输出其底物的继发结果;这些PXE因子随后从循环中渗透到结缔组织中,并阻止弹性纤维的初始沉积或促进最终导致其钙化的结构改变。为了检验这一假设,我们提出了两个具体的目标,对应于(i)皮肤成纤维细胞培养物中存在的来自PXE患者的血清诱导的弹性纤维缺陷的分子表征(ii)负责这些缺陷的血清因子的鉴定。我们希望我们提出的实验将导致识别的因素(S)干扰弹性纤维和可能的发展的治疗措施,减轻症状的PXE。我们还期望从我们的研究中对血管组织中弹性纤维的形成和衰老有一个新的认识水平。公共卫生关系:弹性纤维是大的、复杂的分子,其通过向弹性组织提供特定的机械特性而对生命很重要。为了了解弹性纤维是如何随着时间的推移而保持的,我们正在探索弹性假黄瘤的病理机制,这是一种遗传性疾病,其特征是进行性弹性纤维断裂和钙化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OLIVIER LE SAUX其他文献

OLIVIER LE SAUX的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OLIVIER LE SAUX', 18)}}的其他基金

Resource Core
资源核心
  • 批准号:
    10013267
  • 财政年份:
    2017
  • 资助金额:
    $ 18.75万
  • 项目类别:
Resource Core
资源核心
  • 批准号:
    9211066
  • 财政年份:
    2017
  • 资助金额:
    $ 18.75万
  • 项目类别:
Resource Core
资源核心
  • 批准号:
    10252772
  • 财政年份:
    2017
  • 资助金额:
    $ 18.75万
  • 项目类别:
ISOLATION OF THE SERUM FACTOR RESPONSIBLE FOR PSEUDOXANTHOMA ELASTICUM
分离导致弹性假黄瘤的血清因子
  • 批准号:
    7959637
  • 财政年份:
    2009
  • 资助金额:
    $ 18.75万
  • 项目类别:
Pseudoxanthoma elasticum: Elastic fibers alterations and characterization of seru
弹性假黄瘤:弹性纤维改变和血清特征
  • 批准号:
    7892540
  • 财政年份:
    2009
  • 资助金额:
    $ 18.75万
  • 项目类别:
ISOLATION OF THE SERUM FACTOR RESPONSIBLE FOR PSEUDOXANTHOMA ELASTICUM
分离导致弹性假黄瘤的血清因子
  • 批准号:
    7720341
  • 财政年份:
    2008
  • 资助金额:
    $ 18.75万
  • 项目类别:
UHI COBRE: PATHOGENETICS OF RECESSIVE PSEUDOXANTHOMA ELASTICUM
UHI COBRE:隐性弹性假黄瘤的发病机制
  • 批准号:
    7609910
  • 财政年份:
    2007
  • 资助金额:
    $ 18.75万
  • 项目类别:
UHI COBRE: PATHOGENETICS OF RECESSIVE PSEUDOXANTHOMA ELASTICUM
UHI COBRE:隐性弹性假黄瘤的发病机制
  • 批准号:
    7170544
  • 财政年份:
    2005
  • 资助金额:
    $ 18.75万
  • 项目类别:
UHI COBRE: PATHOGENETICS OF RECESSIVE PSEUDOXANTHOMA ELASTICUM
UHI COBRE:隐性弹性假黄瘤的发病机制
  • 批准号:
    6981520
  • 财政年份:
    2004
  • 资助金额:
    $ 18.75万
  • 项目类别:
Resource Core
资源核心
  • 批准号:
    9536845
  • 财政年份:
  • 资助金额:
    $ 18.75万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了